126:1 New Paragraph; Controlled Drug Prescription Health and Safety Program. Amend RSA 126-A:89 by inserting after paragraph VI the following new paragraph:

VI-a. "Integrative pain management" means the systematic combination of a variety of allopathic and non-allopathic services that address the biological, psychological, social, and spiritual needs of the patient. It is person-centered and focuses on maximizing function and wellness. Care plans are developed through a shared decision-making model that reflects the available evidence regarding optimal clinical practice and the person's goals and values.

126:2 Opioid Abatement Advisory Commission; Duties. Amend RSA 126-A:86, I(b)(16) and (17) to read as follows:

(16) Support for public and non-public school programs and services for students with OUD and any co-occurring SUD/MH issues or who have been affected by OUD and any co-occurring SUD/MH issues within their family; and

(17) Support secondary and tertiary prevention through harm reduction programs.

126:3 Effective Date. This act shall take effect 60 days after its passage.

Approved: July 03, 2024

Effective Date: September 01, 2024

126:1 New Paragraph; Controlled Drug Prescription Health and Safety Program. Amend RSA 126-A:89 by inserting after paragraph VI the following new paragraph:

VI-a. "Integrative pain management" means the systematic combination of a variety of allopathic and non-allopathic services that address the biological, psychological, social, and spiritual needs of the patient. It is person-centered and focuses on maximizing function and wellness. Care plans are developed through a shared decision-making model that reflects the available evidence regarding optimal clinical practice and the person's goals and values.

126:2 Opioid Abatement Advisory Commission; Duties. Amend RSA 126-A:86, I(b)(16) and (17) to read as follows:

(16) Support for public and non-public school programs and services for students with OUD and any co-occurring SUD/MH issues or who have been affected by OUD and any co-occurring SUD/MH issues within their family;

(17) Support secondary and tertiary prevention through harm reduction programs. ;

(18) Support medication assisted treatment (MAT) type services which support the pharmaceutical and non-pharmaceutical needs of patients with chronic pain, and/or those with pain who are in hospice and/or palliative care who have responded well to opioid therapy as defined inRSA 318-B:41, II(d)(7), yet have been subject to non-consensual dose reduction, detoxification, and/or abandonment by their providers; and

(19) Support services which increase access to comprehensive, integrative pain management services as an alternative to opioid therapy for those with acute and/or chronic pain and/or those with pain who are in hospice and/or palliative care.

126:3 Effective Date. This act shall take effect 60 days after its passage.

Approved: July 03, 2024

Effective Date: September 01, 2024